Re-endothelialisation after Synergy stent and Absorb bioresorbable vascular scaffold implantation in acute myocardial infarction: COVER-AMI study

BACKGROUND/AIMS: Drug eluting stent (DES) decrease the risk of restenosis by reducing the neointimal response. However, DES may impair strut coverage, and this has been associated with late stent/scaffold thrombosis. Bioresorbable vascular scaffold (BVS) may overcome the risk of stent/scaffold throm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lhermusier, Thibault, Ohayon, Paul, Boudou, Nicolas, Bouisset, Frederic, Campelo-Parada, Francisco, Roncalli, Jerome, Elbaz, Meyer, Carrié, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458694/
https://www.ncbi.nlm.nih.gov/pubmed/30975219
http://dx.doi.org/10.1186/s13063-019-3293-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458694/
https://www.ncbi.nlm.nih.gov/pubmed/30975219
http://dx.doi.org/10.1186/s13063-019-3293-8

Ejemplares similares